S4 File - by Lu Yang (30847)

“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”

Renal function and risk of dementia: a Mendelian randomization study by Haowen Huang (1430386)

“…</p> <p>The findings indicate a significant correlation between each unit increase in cystatin C-based estimated glomerular filtration rate (eGFR-cys) levels was significantly associated with a reduction in the incidence of late-onset Alzheimer’s disease (LOAD) (IVW: OR = 0.35, 95% CI: 0.13–0.91, <i>p</i> = 0.031). …”

Certainty of affect predicted by valence and low, medium, and high trait emotional intelligence Predicted certainty of knowing how you feel in a trial, as predicted by the subject’... by Anthony G. Vaccaro (5964368)

Experimental Investigation of Hydrodynamic Characteristics in Industrial Pulsed Liquid–Liquid Extraction Column by Xiucheng Yu (22634359)

“…An industrial-scale experimental setup featuring a glass pulsed extraction column has been constructed to investigate the effects of pulsation intensity and flow rate on the flow regime, holdup, and mean residence time (MRT) distribution of the dispersed phase in the extraction columns. …”

Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”

Table 1_A national framework for transition to precision medicine.docx by Samaneh Karimi Esboei (20623664)

“…The statistical sample of the study comprised PM specialists, researchers, and patients whose PM plays a significant role in their diagnosis and treatment. …”

Evaluation results. by Briya Tariq (19666901)

“…Results show decreased metal artefacts and a better signal-to-noise ratio (up to 25%) with increased energy bins as compared to reference data. …”

Dataset with steel insert. by Briya Tariq (19666901)

“…Results show decreased metal artefacts and a better signal-to-noise ratio (up to 25%) with increased energy bins as compared to reference data. …”

Reference dataset. by Briya Tariq (19666901)

“…Results show decreased metal artefacts and a better signal-to-noise ratio (up to 25%) with increased energy bins as compared to reference data. …”

Dataset with aluminium insert. by Briya Tariq (19666901)

“…Results show decreased metal artefacts and a better signal-to-noise ratio (up to 25%) with increased energy bins as compared to reference data. …”

Data Sheet 1_Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers.docx by Sergio Sánchez-García (16862127)

“…We found reduced levels in deceased patients when compared to mild or severe patients, concomitant with a decrease in the LXA₄ biosynthetic pathway and an increase in its degradation pathway. …”

Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α₁‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

“…The potency of compound <b>10</b> against ANO1 was comparable to that of <b>Tam</b> (IC₅₀: 4.57 vs 7.22 μM), but its selectivity over α₁-AR was significantly improved. Compared with <b>Tam</b>, the potency of compound <b>10</b> against α_1A-, α_1B-, and α_1D-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”

Discovery of Tamsulosin Derivatives with Shifted Selectivity from the α₁‑Adrenergic Receptor to ANO1 as Potent Antiosteoporotic Agents by Chaoquan Tian (21009122)

“…The potency of compound <b>10</b> against ANO1 was comparable to that of <b>Tam</b> (IC₅₀: 4.57 vs 7.22 μM), but its selectivity over α₁-AR was significantly improved. Compared with <b>Tam</b>, the potency of compound <b>10</b> against α_1A-, α_1B-, and α_1D-AR decreased by 118-fold, 642-fold, and 10,000-fold, respectively. …”